Dietary Fiber and Diabetes

Torres, Nimbe; Ávila-Nava, Azalia; Medina‐Vera, Isabel; Tovar, Armando R.

doi:10.1007/978-3-030-38654-2_9

Cited by 6 publications

(2 citation statements)

References 93 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Type-2 diabetes patients, it has been determined that high fiber intake provides metabolic benefits on glycemic control, hyperinsulinemia and plasma lipids (Gao et al 2020). For this reason, there is no harm in consuming fructose, which is naturally found in fruits, vegetables and other foods, depending on the level of intake, and the consumption of products rich in dietary fibers is encouraged (Satija et al 2016;Torres et al 2020). Agrawal et al (2014) reported an association between vegetarian diet consumption and the occurrence of Type-2 diabetes in a nationally representative sample of 156 participants aged 20-49 years.…”

Section: Diabetes Mellitusmentioning

confidence: 99%

Use of Medical Foods to Fight Chronic Diseases: A Narrative Review

Meral,

Demirdöven

2024

J Agr Sci-Tarim Bili

View full text Add to dashboard Cite

Chronic diseases cannot be treated completely, and therefore often require repeated treatments. This situation leads to long-term drug utilization. Medical foods are as alternative natural drugs in the management and treatment of chronic diseases. Medical foods are specially formulated food to meet the particular nutritional requirements of patients affected by certain diseases. They play an important role in nutritional support for patients in clinical applications such as deglutition, dyspepsia or eating disorders. They considerably enhance the quality of living of patients by reducing drug usage, preventing complications with overuse of drug, and reducing the expenses of treatments. The nutritive value of medical foods can be regulated and personalized depend on disease. They are not drugs, and are exempt from regulations applying to drugs. Each medical food is formulated specifically according to relevant chronic disease. There are no studies on medical foods for different specific diseases with examples from the market in the literature. The examination and compilation of medical foods in an article with examples from the market is all important in terms of both creating new products and filling the gap in the relevant literature. Therefore, the aim of this review is to explain the use of medical foods for Alzheimer, Parkinson, anxiety and sleep disorder, pain syndrome, cancer, infants, inborn errors metabolism, diabetes mellitus, drug-resistant epilepsy, hypertension and indicate why should be preferred instead of drugs. Research on new medical foods should be increased and new formulations should be created.

show abstract

Section: Diabetes Mellitusmentioning

confidence: 99%

Use of Medical Foods to Fight Chronic Diseases: A Narrative Review

Meral,

Demirdöven

2024

J Agr Sci-Tarim Bili

View full text Add to dashboard Cite

show abstract

“…Diabetes, known as a metabolic disorder, is the insensitivity or deficiency of insulin [ 1 ]. Prolonged diabetic impairments may lead to secondary complications.…”

Section: Introductionmentioning

confidence: 99%

In vitro and in vivo evaluations of antioxidative, anti-Alzheimer, antidiabetic and anticancer potentials of hydroponically and soil grown Lactuca sativa

Naseem

Ismail

2022

BMC Complement Med Ther

View full text Add to dashboard Cite

Background Lactuca sativa is an edible plant commonly used by local communities to manage diabetes and stomach problems. Methods This work aimed to investigate the anti-oxidant, anticancer, antidiabetic and Anti-Alzheimer effects of hydroponically (HyL) and soil-grown (SoL) Lactuca sativa. Streptozotocin-induced diabetes and AlCl3-induced Alzheimer’s disease model was used to evaluate the medicinal effects of Lactuca sativa. Results HyL showed significant activity in lipid peroxidation assay, DPPH and DNA protection assay, while SoL extract showed moderated activity, respectively. A similar activity response was quantified for α-glucosidase, α-amylase, acetylcholinesterase and butyrylcholinesterase inhibition assays. The cytotoxic potential of HyL and SoL extracts against MCF7, and HePG2 cancer cell lines exhibited significant activity. HyL and SoL showed a substantial decrease in blood glucose levels in streptozotocin-induced diabetic rats. Diabetes-related liver/kidney biomarkers and anti-oxidant enzyme trends moved toward normal after HyL and SoL treatment. In Anti-Alzheimer’s based Morris water and elevated plus maze tests, HyL and SoL displayed memory-enhancing response and anti-anxiety behaviour, respectively. HPLC quantification of dopamine and serotonin revealed a moderate but significant (p<0.05) increase in the level of these neurotransmitters in HyL and SoL groups. Conclusion Overall, the study revealed that hydroponic Lactuca sativa possesses the therapeutic potential to treat diseases like Alzheimer’s and diabetes.

show abstract